Kiromic Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kiromic Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Kiromic Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.07M, a 36.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.07M -$619K -36.6% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.23M -$607K -33% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.39M -$597K -30.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.54M -$574K -27.1% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.69M -$472K -21.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.84M -$458K -19.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.99M -$242K -10.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.12M Dec 31, 2022 10-K 2024-03-19
Q3 2022 $2.16M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.3M Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $2.23M Mar 31, 2022 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.